Sentences with phrase «obstructive sleep apnoea»
Pathophysiology and Treatment Options in Obstructive Sleep Apnoea: A Review of the Literature
http://www.scirp.org/
Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology.
Obesity leads also to obstructive sleep apnoea, which has increased in prevalence steadily over the past decade across all EU countries.
• Novel approaches to maintaining upper airway patency and promoting weight reduction in obstructive sleep apnoea.
Tests of 159 drivers at one anonymous haulage company showed that 9 per cent suffered from severe cases of obstructive sleep apnoea, in which the throat becomes blocked during sleep.
In four to five per cent of middle - aged people, these problems lead to sleepiness in the daytime, classified as obstructive sleep apnoea syndrome.
Obstructive sleep apnoea (OSA) is a condition that causes interrupted breathing during sleep.
Obstructive sleep apnoea and sight threatening retinopathy: A novel association in patients with Type 2 diabetes A A Tahrani1, 2, A Ali3, S Begum3, P Galsworthy2, 4, H Wharton2, 4, D Banerjee3, S Taheri1, 2, A H Barnett1, 2, M J Stevens1, 2, P M Dodson2, 4 1Centre of Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK 2Department of Diabetes and Endocrinology, Birmingham Heartlands Hospital, Birmingham, UK 3The Biomedical Unit, Birmingham Heartlands Hospital, Birmingham, UK 4Heart of England Diabetic Retinopathy Screening Centre of Excellence, Birmingham Heartlands Hospital, Birmingham, UK.
Only one in four people with obstructive sleep apnoea are diagnosed with the condition.
He contributes to other large - scale clinical trials including SAVE (evaluating whether treatment of obstructive sleep apnoea with continuous positive airways pressure can reduce the incidence of serious CV events in patients with established CVD), and CREDENCE, a randomised, double - blind, placebo - controlled trial assessing whether canagliflozin can slow the progression of diabetic nephropathy in patients with type 2 diabetes.